Anticancer Research | Special Issues 2025
New Anticancer Agents – 2025
1. TOPICS: A. Experimental studies on “New Anticancer Agents”
1. Synthesis and evaluation in vitro and in vivo
2. Mechanism of action
3. Reversal of resistance to anticancer agents
4. Oncolytic viruses
B. Clinical studies on “New Anticancer Agents”
1. Pharmacology
2. Clinical trials
3. Combination chemotherapy
4. Immunotherapeutic agents
5. New methodologies in drug delivery
6. Vaccines
2. Deadline for article(s) submission: May 10, 2025.
3. The instructions to Authors of ANTICANCER RESEARCH apply to this special issue, in the same way they apply to any ANTICANCER RESEARCH issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Original articles up to 4 printed pages corresponding to roughly 12 typewritten pages or roughly 4,000 words will not be subject to page charges. Articles exceeding 4 printed pages will be charged US $230 per excess page. Color figures will be charged US $350 per page. Discounts will be provided for long articles or/and articles with >2 color pages.
6. All submitted articles will be peer-reviewed. Upon acceptance each article will be edited for language and style improvements (if needed and at no cost) by our philological department. Authors will receive a response within 3-4 weeks from submission.
7. The special issue is scheduled for publication in July, 2025.
8. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
Advances in Renal Cell Carcinoma Diagnosis and Treatment– 2025
1. TOPICS: A. Advances in Renal Cell Carcinoma (RCC) Diagnosis
1. Biomarkers and molecular diagnostics
2. Imaging techniques
3. Non-invasive diagnostic tools
4. Risk stratification and prediction models
B. Advances in Renal Cell Carcinoma (RCC) Treatment
1. Targeted therapies
2. Immunotherapy
3. Combination treatment strategies
4. New methodologies in drug delivery
5. Surgical approaches and minimally invasive techniques
6. Metastatic renal cell carcinoma
7. Adverse effects and quality of life
C. Future Directions and Emerging Trends
1. Personalized and precision medicine in RCC
2. Clinical trials and emerging agents
3. Artificial intelligence in RCC treatment and diagnosis
2. Deadline for article(s) submission: July 10, 2025.
3. The instructions to Authors of ANTICANCER RESEARCH apply to this special issue, in the same way they apply to any ANTICANCER RESEARCH issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Original articles up to 4 printed pages corresponding to roughly 12 typewritten pages or roughly 4,000 words will not be subject to page charges. Articles exceeding 4 printed pages will be charged US $230 per excess page. Color figures will be charged US $350 per page. Discounts will be provided for long articles or/and articles with >2 color pages.
6. All submitted articles will be peer-reviewed. Upon acceptance each article will be edited for language and style improvements (if needed and at no cost) by our philological department. Authors will receive a response within 3-4 weeks from submission.
7. The special issue is scheduled for publication in October 2025.
8. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
In Vivo | Special Issues 2025
Circulating Tumor Cells: Cellular and Molecular Biology; Applications in Cancer Diagnosis and Prognosis – 2025
1. TOPICS: A. Cellular and Molecular Biology of Circulating Tumor Cells (CTCs)
1. Biogenesis and release of CTCs
2. CTC heterogeneity and molecular characterization
3. Circulating tumor cells and tumor microenvironment
4. Mechanisms of CTC resistance
B. Applications in Cancer Diagnosis and Prognosis
1. CTCs as liquid biopsy
2. CTCs for early detection and prognosis
3. CTCs in metastasis and cancer progression
4. CTC-based personalized medicine
5. New methodologies in drug delivery
6. Vaccines
2. Deadline for article(s) submission: May 30, 2025.
3. The instructions to Authors of ΙN VIVO apply to this special issue, in the same way they apply to any ΙN VIVO issue.
4. Upon acceptance, Authors will be asked to pay an online publication fee of USD 1,000 for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
5. All submitted articles will be peer-reviewed. Upon acceptance each article will be edited for language and style improvements (if needed and at no cost) by our philological department. Authors will receive a response within 3-4 weeks from submission.
6. The special issue is scheduled for publication in September 2025.
7. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
Diabetes: New Antidiabetic Agents; Stem Cell Therapy; Pancreas Transplantation – 2025
1. TOPICS: A. New Antidiabetic Agents
1. Development of novel antidiabetic drugs
2. Overcoming drug resistance
3. Combination therapies
4. Oncolytic viruses
B. Stem Cell Therapy in Diabetes
1. Stem cell-based regenerative therapies
2. Stem cell-derived pancreatic cells
3. Overcoming immune rejection in stem cell therapy
C. Pancreas Transplantation
1. Advances in pancreas transplant techniques
2. Pancreatic islet transplantation
3. Immunosuppression in pancreas transplantation
2. Deadline for article(s) submission: September 30, 2025.
3. The instructions to Authors of ΙN VIVO apply to this special issue, in the same way they apply to any ΙN VIVO issue.
4. Upon acceptance, Authors will be asked to pay an online publication fee of USD 1,000 for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
5. All submitted articles will be peer-reviewed. Upon acceptance each article will be edited for language and style improvements (if needed and at no cost) by our philological department. Authors will receive a response within 3-4 weeks from submission.
6. The special issue is scheduled for publication in January 2026.
7. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
In Vivo, in Vitro and in Silico Characterization of Permanent and Biodegradable Implants
Guest Editors: Mike Barbeck, Ole Jung, Rumen Krastev, Meike Stiesch, Frank Walther
We aim to share new insights on material developments and properties alongside biomaterial interactions for tissue regeneration. We invite studies on new and existing biomaterials, including innovative processing techniques. Contributions in the form of reviews or original papers are highly encouraged for this Special Issue.
Suggested topics:
– Biomaterials
– Tissue regeneration
– Cell and tissue responses
– (Biomaterial-related) Inflammation
– Biomechanics
– Lattice Structures
– Damage evolution
– Surface modification
– Titanium/Ti6AL4V
– MagnesiumAdditive manufacturing
– Proteins at Biomaterial Surfaces
- Deadline for article(s) submission: December 31, 2024.
- The Instructions for Authors of In Vivo apply to this special issue, in the same way they apply to any IV issue.
- The special issue is scheduled for publication in May 2025.
- Manuscripts should be submitted for publication through our online submission system: www.iiar-submissions.com.
Cancer Genomics & Proteomics | Special Issues 2025
Cancer Invasion and Metastasis Mechanisms – 2025
1. TOPICS: A. Mechanisms of Cancer Invasion
1. Epithelial-to-Mesenchymal transition (EMT)
2. Tumor microenvironment and invasion
3. Extracellular matrix degradation
B. Mechanisms of Metastasis
1. Circulating tumor cells and metastasis
2. Pre-metastatic niche formation
3. Organotropism in metastasis
4. Resistance to antimetastatic agents
2. Deadline for article(s) submission: May 30, 2025.
3. The instructions to Authors of CANCER GENOMICS & PROTEOMICS apply to this special issue, in the same way they apply to any CANCER GENOMICS & PROTEOMICS issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Upon acceptance, Authors will be asked to pay an online publication fee of USD 1,100 for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
6. The special issue is scheduled for publication in September 2025.
7. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
Transcriptomics: Identification of Fusion Transcripts; Non-coding RNAs; Discovery of New Transcripts – 2025
1. TOPICS: A. Identification of Fusion Transcripts
1. Detection and characterization of fusion genes
2. Role of fusion transcripts in cancer
B. Non-coding RNAs
1. Role of microRNAs and lncRNAs in gene regulation
2. Non-coding RNAs as biomarkers
C. Discovery of New Transcripts
1. Advances in transcriptomic profiling
2. Functional characterization of novel transcripts
2. Deadline for article(s) submission: September 30, 2025.
3. The instructions to Authors of CANCER GENOMICS & PROTEOMICS apply to this special issue, in the same way they apply to any CANCER GENOMICS & PROTEOMICS issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Upon acceptance, Authors will be asked to pay an online publication fee of USD 1,100 for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
6. The special issue is scheduled for publication in January 2026.
7. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
Cancer Diagnosis & Prognosis | Special Issues 2025
New Tumor Markers – 2025
1. TOPICS: A. Discovery of Novel Tumor Markers
1. Genomic and proteomic approaches
2. Tumor markers for early detection
B. Tumor Markers for Prognosis and Treatment Response
1. Prognostic markers in cancer
2. Tumor markers for monitoring therapeutic response
2. Deadline for article(s) submission: August 30, 2025.
3. The instructions to Authors of CANCER DIAGNOSIS & PROGNOSIS apply to this special issue, in the same way they apply to any CANCER DIAGNOSIS & PROGNOSIS issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Upon acceptance, Authors will be asked to pay an online publication fee of USD 600.00 (effective April 1, 2021) for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
6. The special issue is scheduled for publication in November 2025. 7. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
Immunohistochemistry (IHC) in Cancer Diagnosis and Prognosis – 2025
1. TOPICS: A. Advances in Immunohistochemical Techniques
1. Development of new antibodies
2. Multiplex immunohistochemistry
B. Immunohistochemistry in Cancer Diagnosis
1. Diagnostic applications in solid tumors
2. Immunohistochemistry in early detection
C. Prognostic Applications of Immunohistochemistry
1. Prognostic biomarkers identified by IHC
2. IHC for monitoring treatment response
2. Deadline for article(s) submission: April 30, 2025.
3. The instructions to Authors of CANCER DIAGNOSIS & PROGNOSIS apply to this special issue, in the same way they apply to any CANCER DIAGNOSIS & PROGNOSIS issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Upon acceptance, Authors will be asked to pay an online publication fee of USD 600.00 (effective April 1, 2021) for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
6. The special issue is scheduled for publication in July 2025. 7. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com